(Q34347152)

1 August 2017

Estrogen receptor ligands: a patent review update (English)

1 reference

1 August 2017

Simone Bertini

2

0 references

Carlotta Granchi

object named as

Carlotta Granchi

series ordinal

3

0 references

Filippo Minutolo

object named as

Filippo Minutolo

series ordinal

5

0 references

Ilaria Paterni

series ordinal

1

object named as

Ilaria Paterni

1 reference

1 August 2017

Marco Macchia

4

1 reference

PubMed ID

23713677

1 August 2017

language of work or name

English

0 references

publication date

29 May 2013

1 reference

Expert Opinion on Therapeutic Patents

1 August 2017

1 reference

1 August 2017

23

1 reference

1 August 2017

10

1 reference

1 August 2017

1247-1271

1 reference

International Union of Pharmacology. LXIV. Estrogen receptors

1 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

The unfolding stories of GPR30, a new membrane-bound estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Connections and regulation of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Estrogen receptor β ligands: recent advances and biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Development of subtype-selective oestrogen receptor-based therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

The G-protein-coupled estrogen receptor GPER in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Synthesis and biological evaluation of phenolic 4,5-dihydroisoxazoles and 3-hydroxy ketones as estrogen receptor alpha and beta agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Lasofoxifene in postmenopausal women with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Selective estrogen receptor modulators: structure, function, and clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Salicylaldoxime moiety as a phenolic "A-Ring" substitute in estrogen receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

ERbeta ligands. Part 2: Synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

ERbeta ligands. Part 5: synthesis and structure-activity relationships of a series of 4'-hydroxyphenyl-aryl-carbaldehyde oxime derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

GPR30: a novel therapeutic target in estrogen-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Structural insights into the mode of action of a pure antiestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Cloning of a novel receptor expressed in rat prostate and ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Preclinical characterization of a novel diphenyl benzamide selective ERα agonist for hormone therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

The selective estrogen receptor alpha agonist Org 37663 induces estrogenic effects but lacks antirheumatic activity: a phase IIa trial investigating efficacy and safety of Org 37663 in postmenopausal female rheumatoid arthritis patients receiving st

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Soya isoflavone supplementation enhances spatial working memory in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-substituted 3,4-diarylsalicylaldoximes on estrogen receptors alpha and beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

Selective and potent agonists for estrogen receptor beta derived from molecular refinements of salicylaldoximes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.805206

10.1517/13543776.2013.805206

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

23713677